Author: Medical Channel Asia

Avatar photo

Medical Channel Asia (MCA) is built to be the largest and most reliable health media platform in Asia that supports healthcare professionals in delivering engaging educational content. MCA is growing exponentially on multiple social media and digital platforms with its content catered to the Asian population covering wellness, health and fitness topics.

Singapore, 26 May 2025 – Researchers from the Critical Analytics for Manufacturing Personalized-Medicine (CAMP) and Antimicrobial Resistance (AMR) interdisciplinary research groups (IRGs) of Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, and KK Women’s and Children’s Hospital (KKH), have developed a first-of-its-kind device to profile the immune function of newborns.   

Read More
Singapore, 14 May 2025 – The Health Sciences Authority (HSA) has approved Dupixent (dupilumab) for adults as an add-on maintenance treatment for uncontrolled chronic obstructive pulmonary disease (COPD) characterized by raised blood eosinophils who are on a stable combination of an inhaled corticosteroid (ICS), a long-acting beta2-agonist (LABA), and a long-acting muscarinic antagonist (LAMA), or on a combination of a LABA and a LAMA if ICS is not appropriate.

Log In or Register as a healthcare professional to read the full article.

Read More